Is it Useful to Classify PSP and CBD as Different Disorders? Yes
- PMID: 30363457
- PMCID: PMC6174492
- DOI: 10.1002/mdc3.12581
Is it Useful to Classify PSP and CBD as Different Disorders? Yes
Keywords: corticobasal degeneration; neural network; prion; progressive supranuclear palsy; tau strain.
Similar articles
-
Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration.Neuropathology. 2014 Dec;34(6):555-70. doi: 10.1111/neup.12143. Epub 2014 Aug 14. Neuropathology. 2014. PMID: 25124031 Review.
-
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.Neurology. 2006 Jan 10;66(1):41-8. doi: 10.1212/01.wnl.0000191307.69661.c3. Neurology. 2006. PMID: 16401843
-
Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy.J Neurol Sci. 2001 Jan 15;183(1):95-8. doi: 10.1016/s0022-510x(00)00480-9. J Neurol Sci. 2001. PMID: 11166802
-
Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.J Neurol. 1999 Sep;246 Suppl 2:II6-15. doi: 10.1007/BF03161076. J Neurol. 1999. PMID: 10525997 Review.
-
A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy.Neurosci Lett. 1999 Jan 8;259(2):127-9. doi: 10.1016/s0304-3940(98)00923-9. Neurosci Lett. 1999. PMID: 10025574
Cited by
-
Temporal Progression Patterns of Brain Atrophy in Corticobasal Syndrome and Progressive Supranuclear Palsy Revealed by Subtype and Stage Inference (SuStaIn).Front Neurol. 2022 Feb 25;13:814768. doi: 10.3389/fneur.2022.814768. eCollection 2022. Front Neurol. 2022. PMID: 35280291 Free PMC article.
-
Comment on "Is it Useful to Classify PSP and CBD as Different Disorders?".Mov Disord Clin Pract. 2018 Oct 3;5(5):564-565. doi: 10.1002/mdc3.12676. eCollection 2018 Sep-Oct. Mov Disord Clin Pract. 2018. PMID: 30515448 Free PMC article. No abstract available.
-
Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.Dtsch Arztebl Int. 2019 Nov 1;116(44):747-754. doi: 10.3238/arztebl.2019.0747. Dtsch Arztebl Int. 2019. PMID: 31774054 Free PMC article. Review.
-
A Rare Case of Asymmetric Progressive Supra Nuclear Palsy Diagnosed In vivo with Magnetic Resonance/Positron Emission Tomography.Indian J Nucl Med. 2023 Apr-Jun;38(2):165-166. doi: 10.4103/ijnm.ijnm_170_22. Epub 2023 Jun 8. Indian J Nucl Med. 2023. PMID: 37456195 Free PMC article.
-
Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review.Neurol Ther. 2024 Aug;13(4):975-1013. doi: 10.1007/s40120-024-00614-9. Epub 2024 May 14. Neurol Ther. 2024. PMID: 38743312 Free PMC article. Review.
References
-
- Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964(10):333‐359. - PubMed
-
- Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP‐parkinsonism. Brain 2005;128(Pt 6):1247‐1258. - PubMed
-
- Rebeiz JJ, Kolodny EH, Richardson EP, Jr . Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968;18(1):20‐33. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous